Oncocross
Discovering drugs that can satisfy unmet needs in numerous diseases and medical conditions.
Launch date
Employees
Market cap
-
Enterprise valuation
€88m (Public information from Nov 2023)
Company register number 4828600109
Seoul South Korea (HQ)
Authorizing premium user...